| CXCR | C-X-C chemokine receptor |
| CXCL | C-X-C motif chemokine ligand |
| CCL | chemokine C-C motif ligand |
| ROS | reactive oxygen species |
| NETs | neutrophil extracellular traps |
| CVD | cardiovascular disease |
| ECM | extracellular matrix |
| LDL | low-density lipoprotein |
| MPO | myeloperoxidase |
| PMA | phorbol-12-myristate-13-acetate |
| IL | interleukin |
| PBMC | peripheral blood mononuclear cell |
| MI | myocardial infarction |
| Th 17 | cells T helper 17 cells |
| PAD4 | peptidyl arginine deiminase 4 |
| HMGB1 | high mobility group box 1 |
| NASH | non-alcoholic steatohepatitis |
| MACE | major adverse cardiovascular events |
| SLE | systemic lupus erythematosus |
| LDLr−/− | LDL receptor knockout |
| TMAs | thrombotic microangiopathies |
| PSGL-1 | P-selectin glycoprotein ligand 1 |
| Myd88 | myeloid differentiation primary response 88 |
| RAGE | receptor for advanced glycation end-products |
| CGD | chronic granulomatous disease |
| IRAKs | Interleukin-1 receptor associated kinase |
| MAPK | mitogen-activated protein kinase |
| SK | calcium-activated small conductance potassium |
| TLR | toll-like receptor |
| PF4 | platelet factor 4 |